Facilitated By

San Antonio Medical Foundation

News

  • Seattle's Nautilus Biotechnology lays off 16% of its staff - Puget Sound Business Journal

    San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Nautilus Biotechnology CEO Sujal Patel, left, and Parag Mallick ...

  • Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

    (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 ... Presented two posters at the San Antonio Breast Cancer Symposium.

  • PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of ...

    PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA. PharmAla Biotech - (GLOBE NEWSWIRE); Feb 27, 2025; 13 ...

  • PharmAla Advances MDMA Trial for Military PTSD Treatment - TipRanks.com

    PharmAla Biotech Holdings Inc. has announced the progression of its contract with the University of Texas Health Science Center at San Antonio, funded ...

  • PharmAla Develops New MDMA Dosage for $10M DoD-Funded PTSD Study in Military Personnel

    PharmAla Biotech Holdings (OTC:MDXXF) has announced advancement of its contract with UT Health San Antonio for the STRONG STAR Consortium study, ...